Premium
Brainstorm Cell Therapeutics Inc (BCLI)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's d... Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.31 | 15.6565656566 | 1.98 | 2.33 | 1.86 | 81021 | 2.14528984 | CS |
| 4 | -0.1077 | -4.49180464612 | 2.3977 | 2.4893 | 1.86 | 67977 | 2.18789325 | CS |
| 12 | 0.41 | 21.8085106383 | 1.88 | 2.5 | 1.05 | 111184 | 1.74175302 | CS |
| 26 | -2.8115 | -55.1112417916 | 5.1015 | 6 | 1.05 | 221156 | 3.70010484 | CS |
| 52 | -2.7095 | -54.195419542 | 4.9995 | 11.890485 | 1.05 | 513244 | 6.32545956 | CS |
| 156 | -42.86 | -94.9280177187 | 45.15 | 70.5 | 1.05 | 640779 | 10.53812855 | CS |
| 260 | -60.86 | -96.3737133808 | 63.15 | 269.25 | 1.05 | 653031 | 47.79537422 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
